A supplement-trading enquiry included a tablet flagged for restricted ingredients, requiring classification before a registration route could be chosen.
Trading reference only. Product classification and registration are separate; this code is not approval of a restricted ingredient or a medicinal product.
Activity 4721016 · Dubai mainland · DET reference
Includes reselling the supplements which are classified as food and not drugs and are intended to provide nutrients which might be lacked in the food or otherwise not be consumed in sufficient quantities, it involves vitamins, minerals, fiber, fatty acids, or amino acids, honey and herbal tonics, nourishing substitutes for athletes and diet recipes.
Find this activity in the directoryRead the requirement, the constraint and the proposed route together. The value of this case is the reasoning behind the setup, rather than an activity name in isolation.
Four phases, 9 checkpoints. See the route at a glance, then open a checkpoint for the work, owner and timing. Daily updates continue during active work.
Confirm the route and open your file.
Activity, legal form and Dubai mainland
Owner / You and VantablackNamed team, checklist and your project timeline
Owner / VantablackDocuments and activity checks.
Passports, KYC and anything the activity needs
Owner / You, checked by VantablackSubmitted to the Department of Economy and Tourism
Owner / Vantablack, then the authorityPremises and the licence decision.
Lease and Ejari for the dedicated premises
Owner / You and VantablackYour company exists; documents in your workspace
Owner / The authorityFollow-on work in your agreed scope.
Immigration file for you and your team
Owner / Vantablack PRO teamBank application, VAT and Corporate Tax registration
Owner / Vantablack and the bankList your services on the Ecosystem and receive requests
Owner / You, on VantablackTime markers are our service standards; authority steps follow the authority’s own timeline, and approvals are the authority’s decision. Your accepted quote confirms which post-licence services are included. Sales depend on licensing, approvals and demand.
Select a point to read the reasoning.
A supplement-trading enquiry included a tablet flagged for restricted ingredients, requiring classification before a registration route could be chosen.
The client wanted a Dubai supplement-trading company and registration of a small product portfolio. One tablet was flagged for restricted ingredients. The ingredient and authority determination are not recorded publicly, so its registration route remained unresolved.
Separate the company activity from product classification. Review the formula, dose, claims, artwork and evidence; obtain an authority determination where uncertain. Hold the flagged tablet until resolved. The record does not establish whether it was reformulated, rerouted or dropped.
DM’s health-supplement guideline requires Montaji registration for products within its scope before market placement in Dubai. Its dossier covers the Free Sale Certificate, ingredient and analysis reports and manufacturing evidence. Review label claims: the guideline prohibits disease prevention, treatment and cure claims.
DM health-supplement guideline 29, sections 7–9 — checked 20 October 2026. Read the official publication.
EDE classifies medical products using presentation, composition, use and design. Its letter determines whether EDE marketing authorisation is required and the applicable category. A restricted ingredient is not automatically acceptable under another route; a classification enquiry is not approval to sell.
EDE: Classification of a Medical Product — checked 20 October 2026. Read the official publication.
The licence status, tablet decision and registrations are unrecorded. Resolve borderline products before choosing the route. Case 61 covers portfolio management; a trading licence or submitted dossier does not prove product registration.
Related investigation: Case 61.
Assess storage, distribution and any customer-facing premises against the actual activity and authority requirements.
Quote company and professional work separately from product dossiers or clinical approvals, premises, equipment and operating costs. No actual case budget or verified authority tariff is supplied here.
Planning guidance, not a statement of this client’s costs or completed approvals. Confirm the specific scope and quotation.
Classification follows what is actually done with patients or products. Corporate formation does not by itself authorise clinical treatment, a health facility or each product.
A clinical service, restricted ingredient, new treatment or additional product can introduce a separate regulatory path.
